Robert L. Baechtold

Senior Counsel
Baechtold Robert
With over 40 years of experience, Bob Baechtold has prepared, tried, and argued intellectual property cases, serving as lead counsel on behalf of major international companies in the fields of pharmaceuticals, biotechnology, chemistry, and polymeric materials. He is widely known as "an excellent patent litigator, especially in the pharmaceutical field" (Best Lawyers in America), "the dean of pharmaceuticals" (Chambers USA), "the greatest that ever was" in pharmaceutical patent litigation, a "top trial lawyer," and "one of the best in the country." (Chambers Global).

Additionally, Bob has argued numerous appeals before the Court of Appeals for the Federal Circuit and has served as president of that court's Bar Association. He has also served as a board member for the American Intellectual Property Law Association and the New York Intellectual Property Law Association and as president of the New Jersey Intellectual Property Law Association.

Bob has extensive experience in arbitrations, both as counsel for the litigants and as an arbitrator. He has served as an arbitrator in United States patent validity and infringement disputes between major companies and in ICC proceedings involving issues of patent and international substantive and procedural laws.


Representative Matters

  • AstraZeneca against Andrx, Genpharm, Dr. Reddy and Schwartz Pharma on patents relating to omeprazole and its formulations.
  • Yamanouchi against Danbury Pharmacal on a patent relating to famotidine, an anti-ulcer drug.
  • G.D. Searle and Pharmacia against the University of Rochester on patents relating to COX-2 inhibitors.
  • Bausch & Lomb against Alcon on patents relating to compositions for disinfecting contact lenses.
  • Emory University against GlaxoWellcome Inc and Biochem Pharma on patents relating to antiviral agents for the treatment of HIV.
  • UCB against Mylan, Dr. Reddy, Sandoz and Cobalt on patents relating to levetiracetam, a leading epilepsy medicine.
  • Astellas against Ranbaxy on patents relating to tamsulosin, used to treat phostatic hypertrophy.
  • Sankyo against Mylan on patents relating to olmesartan medoxomil, an anti-hypertensive.
  • S.C. Johnson & Son against Gillette and Carter-Wallace on a patent relating to Edge® gel shaving cream.
  • American Maize Products against Grain Processing Corp. on patents relating to maltodextrin food additives.
  • Novartis against Eon Laboratories and Abbott Laboratories on patents relating to cyclosporin formulations.
  • E.I. DuPont against Alzo on patents relating to Kevlar® fiber technology.
  • Cetus Corp. against Erbamont on patents relating to the synthesis of doxorubicin.
  • Novartis against Dr. Reddy on a patent relating to terbinafine, an anti-fungal agent.

Representative Clients

  • Astellas Pharma
  • Sanofi
  • UCB Pharma




  • J.D. magna cum laude Seton Hall University School of Law 1966
  • B.S. Rutgers University 1958

Bar Admissions

  • New York
  • New Jersey
  • U.S. Patent and Trademark Office


  • Recognized in Chambers USA, Senior Statesperson, Intellectual Property: Patent, New York, 2019
  • Recognized as a Leading IP Practitioner in the World, WIPR 2017
  • New York City Litigation Patent Lawyer of the Year, Best Lawyers, 2014
  • Top New York City Intellectual Property Litigator, Super Lawyers, 2006-2017
  • IP Star, Managing Intellectual Property, 2013-2015
  • New York Intellectual Property Lawyer of the Year, Best Lawyers, 2011
  • Seton Hall University School of Law’s 2009 Distinguished Graduate